Summary

  • Brady’s $6.25–$6.75 fiscal 2027 adjusted diluted EPS guide has a $6.50 midpoint, about 22.9% above fiscal 2026 adjusted EPS of $5.29. It is a perimeter-changing comparison, not an organic-growth rate.
  • The IPS acquisition closed on 3 August 2026, after Brady’s fiscal year ended on 31 July. Management assigns approximately $0.80 of adjusted EPS to IPS, net of financing cost, but does not allocate the remaining midpoint increase.
  • Continuing IDS organic revenue growth, acquired IPS revenue and margins, integration adjustments, financing and GAAP earnings require separate evidence. They cannot be reconstructed from the 23% headline.

Three days divide the comparator

Brady’s fiscal calendar creates the first analytical boundary. Fiscal 2026 ended on Friday, 31 July. Brady Worldwide completed the $1.4 billion cash acquisition of Honeywell’s Productivity Solutions and Services business on Monday, 3 August. The acquired operation, renamed Intelligent Productivity Solutions, therefore contributed no revenue or operating profit to the fiscal 2026 results used as the guidance comparator.

That does not mean the transaction was absent from the old year. Brady had already incurred financing, legal, administrative and third-party integration costs. The distinction is more exact: acquisition work entered the expense record before the acquired operation entered the consolidated operating perimeter.

Fiscal 2026 itself was not a weak base. Sales rose 9.8% to $1.661565 billion, including 5.3% organic growth. GAAP diluted EPS increased 9.1% to $4.30, while adjusted diluted EPS rose 15.0% to $5.29. Operating cash flow was $244.127 million, up from $181.196 million. Those figures describe Brady before IPS’s operations were consolidated.

What the 23% midpoint measures

For fiscal 2027, Brady guides adjusted diluted EPS to $6.25–$6.75. The midpoint is $6.50. Against $5.29, that is a $1.21 increase, or about 22.9%. The company rounds the midpoint comparison to 23%.

Management provides one important piece of the bridge: approximately $0.80 of adjusted EPS accretion from IPS, net of the cost of financing the transaction, with most of the contribution expected in the second half as the business is integrated. Arithmetically, that amount is about two-thirds of the midpoint increase. It is the only part of the $1.21 bridge that the guidance release explicitly assigns to IPS.

The remaining roughly $0.41 is not a disclosed “organic EPS” figure. Subtraction produces a residual, not its explanation. The release does not allocate that residual among continuing operations, foreign exchange, tax, share count, corporate costs, purchase accounting or other items. Nor does it provide fiscal 2027 GAAP EPS. Calling the whole 23% organic, or calling the residual organic, would add a conclusion that the filing does not supply.

Revenue gives two operating receipts, not one rate

Brady’s revenue guidance reinforces the perimeter split. Management expects the continuing Identification Solutions segment to grow revenue approximately 5% organically. Separately, it expects IPS to contribute about $1.15 billion of revenue in fiscal 2027. One is a growth rate for a continuing segment; the other is revenue from an acquired segment that was not present in the prior-year operating base.

The margin expectations are separate too: about 20% for IDS and low double digits for IPS. Those figures make mix consequential. Adding a large segment at a lower expected margin can lift consolidated adjusted EPS while changing the composition of sales and profit. The result may be attractive or disappointing; the guide alone does not settle it. It simply requires the acquired contribution to be identified rather than relabelled as organic expansion.

The operating handover is also unfinished by design. At closing, Honeywell and Brady Worldwide entered reciprocal limited transition-service arrangements, and the parties signed an intellectual-property licence governing technology used by the business. These agreements are normal evidence of separation dependencies. They are neither proof of disruption nor proof that integration is complete.

The adjusted comparator carries its own exclusions

The fiscal 2026 starting point of $5.29 is non-GAAP. Brady reconciles it from $4.30 of GAAP diluted EPS by adding $0.33 of amortisation expense, $0.56 of non-recurring acquisition-related costs and other related expenses, and $0.10 of executive-transition costs. The acquisition-related category includes third-party integration support, financing fees, legal and other administrative expenses.

That reconciliation is useful because it shows what the comparator removes. It does not tell readers what fiscal 2027 GAAP EPS will be, how acquisition accounting will affect amortisation, or how much future integration expense will be excluded. A like-for-like adjusted comparison can illuminate operating expectations while remaining different from the eventual statutory earnings record.

Financing changed after the balance-sheet photograph

At 31 July, Brady reported $187.149 million of cash and $14.985 million of long-term debt. Management described a $172.2 million net cash position. Three days later, the company said it had incurred approximately $800 million under its credit agreement and approximately $800 million under private-placement notes to fund the transaction and related fees alongside cash on hand.

The fixed-rate notes carry coupons of 5.43%, 5.65% and 5.90% and mature in 2031, 2033 and 2036. The bank facility adds a variable-rate and amortising layer. Gross closing borrowings of roughly $1.6 billion are not the same as final net debt, and the note coupons are not the complete financing cost. They do show why “net of financing” is a material qualification to the $0.80 accretion estimate.

At announcement, management expected at least $25 million of annual run-rate cost synergies within three years and net debt to EBITDA below two times within two years of closing. Both are forward-looking tests. They should be assessed against later integration costs, segment profit, cash generation and actual debt reduction, not booked as accomplished value today.

The narrow reading

Brady’s 23% midpoint is a useful guide when its boundaries remain attached. It compares an adjusted pre-IPS year with an adjusted year expected to include IPS; it identifies approximately $0.80 of acquired accretion net of financing; and it leaves the rest of the earnings bridge unallocated.

The disciplined conclusion is therefore not that Brady lacks organic growth. Fiscal 2026 and the IDS guide both contain organic revenue evidence. It is that the 23% figure measures a broader change. The next year combines a continuing business, a new operating perimeter, integration choices and a new capital structure. Each deserves its own receipt.

Sources

  1. Brady fiscal 2026 results and fiscal 2027 guidance
  2. Brady Form 8-K reporting the IPS closing and financing
  3. Brady Form 8-K reporting the June 2026 credit agreement
  4. Brady’s April 2026 acquisition announcement